Astrosalva Therapeutics Adds Rare Disease Patient Advocacy Leader Wendy Erler to Strategic Advisory Board
Erler, Senior Vice President of Patient Affairs at Sarepta Therapeutics, will advise Astrosalva on patient and community engagement and patient-focused drug development in Alexander disease and cALD SAN MATEO, Calif., Nov. 5, 2026 /PRNewswire/ -- Astrosalva Therapeutics, Inc....
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 96 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.